TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dental Arches Response to Haas-type RME Anchored to Deciduous vs Permanent Molars in Children With Unilateral Posterior Crossbite
Brief Summary: Posterior crossbite is a common clinical condition often associated with transverse maxillary deficiency and functional mandibular shift. This frequent malocclusion is not self-correcting and can lead to the development of craniofacial asymmetries and mandibular dysfunction.

The aim of the current study was to evaluate maxillary and mandibular arch widths' response to RME when it is anchored to the upper second deciduous molars or to the upper first permanent molars and to create a decision-making protocol for RME therapy in mixed-dentition patients.


Options:
A: Arm Label: Heat-Activated Nickel-Titanium Archwires; Type: EXPERIMENTAL; Interventions: Procedure: Orthodontic treatment | Arm Label: Superelastic Nickel-Titanium Archwires; Type: EXPERIMENTAL; Interventions: Procedure: Orthodontic treatment | Intervention Type: PROCEDURE; Name: Orthodontic treatment; Assigned to Arm(s): Heat-Activated Nickel-Titanium Archwires, Superelastic Nickel-Titanium Archwires
B: Arm Label: AcceleDent vibrational device; Type: EXPERIMENTAL; Interventions: Device: AcceleDent vibrational device | Arm Label: Sham AcceleDent device; Type: SHAM_COMPARATOR; Interventions: Device: Sham AcceleDent device | Arm Label: Fixed appliance only; Type: ACTIVE_COMPARATOR; Interventions: Other: Fixed appliance only | Intervention Type: DEVICE; Name: AcceleDent vibrational device; Assigned to Arm(s): AcceleDent vibrational device | Intervention Type: DEVICE; Name: Sham AcceleDent device; Assigned to Arm(s): Sham AcceleDent device | Intervention Type: OTHER; Name: Fixed appliance only; Assigned to Arm(s): Fixed appliance only
C: Arm Label: RME on upper first permanent molars; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Rapid maxillary expansion | Arm Label: RME on upper second deciduous molars; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Rapid maxillary expansion | Intervention Type: PROCEDURE; Name: Rapid maxillary expansion; Assigned to Arm(s): RME on upper first permanent molars, RME on upper second deciduous molars
D: Arm Label: Piezosurgery; Type: EXPERIMENTAL; Interventions: Procedure: Piezosurgery | Arm Label: Ordinary Alignment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Piezosurgery; Assigned to Arm(s): Piezosurgery

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial
Brief Summary: For the past 130 years, appendectomy has been the standard treatment for appendicitis. Recent studies from Europe have challenged the notion that surgery is the best option, showing that antibiotics alone can treat appendicitis without a need for appendectomy in as many as 3 out of 4 patients and without safety issues for up to one year of follow up. Despite these results, it remains to be determined if the antibiotic strategy is as good as an appendectomy for the outcomes that most patients care about. The Patient-Centered Outcomes Research Institute (PCORI)-funded Comparison of Outcomes of Drugs and Appendectomy (CODA) trial will be the first American, and largest-ever randomized trial of the issue and its results should help surgeons and patients make more informed healthcare decisions.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Procedure: appendectomy | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: amoxicillin/clavulanate potassium | Intervention Type: DRUG; Name: amoxicillin/clavulanate potassium; Assigned to Arm(s): B | Intervention Type: PROCEDURE; Name: appendectomy; Assigned to Arm(s): A
B: Arm Label: Antibiotics Therapy Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin | Arm Label: Appendectomy Arm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Appendectomy | Intervention Type: DRUG; Name: Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin; Assigned to Arm(s): Antibiotics Therapy Arm | Intervention Type: PROCEDURE; Name: Appendectomy; Assigned to Arm(s): Appendectomy Arm
C: Arm Label: Low-dose CT; Type: EXPERIMENTAL; Interventions: Radiation: Diagnostic CT | Arm Label: Standard-dose CT; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Diagnostic CT | Intervention Type: RADIATION; Name: Diagnostic CT; Assigned to Arm(s): Low-dose CT | Intervention Type: RADIATION; Name: Diagnostic CT; Assigned to Arm(s): Standard-dose CT
D: Arm Label: Operative treatment; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Appendicectomy | Arm Label: Antibiotic treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ertapenem | Intervention Type: PROCEDURE; Name: Appendicectomy; Assigned to Arm(s): Operative treatment | Intervention Type: DRUG; Name: Ertapenem; Assigned to Arm(s): Antibiotic treatment

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Study of Stochastic Vibrotactile Stimulation for Neonatal Abstinence Syndrome: Therapeutic Efficacy and Neurobehavioral Outcomes
Brief Summary: The purpose of this study is to examine the efficacy of a specially-constructed crib mattress that delivers gentle vibrations (stochastic vibrotactile stimulation) as a complementary, non-pharmacological intervention for treating drug withdrawal in newborns exposed to opioids in utero.


Options:
A: Arm Label: Low lactose formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Low lactose or regular formula | Arm Label: Regular formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Low lactose or regular formula | Intervention Type: OTHER; Name: Low lactose or regular formula; Assigned to Arm(s): Low lactose formula, Regular formula
B: Arm Label: Standard therapy plus Aromatherapy; Type: EXPERIMENTAL; Interventions: Drug: lavender and chamomile essential oils | Arm Label: Standard therapy ALONE; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: lavender and chamomile essential oils; Assigned to Arm(s): Standard therapy plus Aromatherapy
C: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
D: Arm Label: Stochastic Vibrotactile Stimulation (SVS); Type: EXPERIMENTAL; Interventions: Device: Stochastic Vibrotactile Stimulation (SVS) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Stochastic Vibrotactile Stimulation (SVS); Assigned to Arm(s): Stochastic Vibrotactile Stimulation (SVS)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Study of Stochastic Vibrotactile Stimulation for Neonatal Abstinence Syndrome: Therapeutic Efficacy and Neurobehavioral Outcomes
Brief Summary: The purpose of this study is to examine the efficacy of a specially-constructed crib mattress that delivers gentle vibrations (stochastic vibrotactile stimulation) as a complementary, non-pharmacological intervention for treating drug withdrawal in newborns exposed to opioids in utero.


Options:
A: Arm Label: Stochastic Vibrotactile Stimulation (SVS); Type: EXPERIMENTAL; Interventions: Device: Stochastic Vibrotactile Stimulation (SVS) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Stochastic Vibrotactile Stimulation (SVS); Assigned to Arm(s): Stochastic Vibrotactile Stimulation (SVS)
B: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
C: Arm Label: Low lactose formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Low lactose or regular formula | Arm Label: Regular formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Low lactose or regular formula | Intervention Type: OTHER; Name: Low lactose or regular formula; Assigned to Arm(s): Low lactose formula, Regular formula
D: Arm Label: SVS vs Control; Type: EXPERIMENTAL; Interventions: Device: Stochastic Vibrotactile Stimulation (SVS), Other: Control | Intervention Type: DEVICE; Name: Stochastic Vibrotactile Stimulation (SVS); Assigned to Arm(s): SVS vs Control | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): SVS vs Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Study of Stochastic Vibrotactile Stimulation for Neonatal Abstinence Syndrome: Therapeutic Efficacy and Neurobehavioral Outcomes
Brief Summary: The purpose of this study is to examine the efficacy of a specially-constructed crib mattress that delivers gentle vibrations (stochastic vibrotactile stimulation) as a complementary, non-pharmacological intervention for treating drug withdrawal in newborns exposed to opioids in utero.


Options:
A: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
B: Arm Label: Stochastic Vibrotactile Stimulation (SVS); Type: EXPERIMENTAL; Interventions: Device: Stochastic Vibrotactile Stimulation (SVS) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Stochastic Vibrotactile Stimulation (SVS); Assigned to Arm(s): Stochastic Vibrotactile Stimulation (SVS)
C: Arm Label: Song of Kin; Type: EXPERIMENTAL; Interventions: Behavioral: Song of Kin | Arm Label: Gato box; Type: EXPERIMENTAL; Interventions: Other: Gato box | Arm Label: Ocean disc; Type: EXPERIMENTAL; Interventions: Other: Ocean disc | Arm Label: Contingent singing; Type: EXPERIMENTAL; Interventions: Other: Contingent singing | Arm Label: Tonal Vocal holding; Type: EXPERIMENTAL; Interventions: Other: Tonal Vocal holding | Arm Label: Muted shaker; Type: EXPERIMENTAL; Interventions: Other: Muted shaker | Intervention Type: BEHAVIORAL; Name: Song of Kin; Assigned to Arm(s): Song of Kin | Intervention Type: OTHER; Name: Gato box; Assigned to Arm(s): Gato box | Intervention Type: OTHER; Name: Ocean disc; Assigned to Arm(s): Ocean disc | Intervention Type: OTHER; Name: Contingent singing; Assigned to Arm(s): Contingent singing | Intervention Type: OTHER; Name: Tonal Vocal holding; Assigned to Arm(s): Tonal Vocal holding | Intervention Type: OTHER; Name: Muted shaker; Assigned to Arm(s): Muted shaker
D: Arm Label: Methadone maintained lactating women; Type: N/A; Interventions: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study of DU-176b in Patients With NVAF Aged 80 Years or Older Who Are Ineligible for Available Oral Anticoagulation Therapy
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of edoxaban in patients with non-valvular NVAF aged 80 years or older who are ineligible for available oral anticoagulation therapy.


Options:
A: Arm Label: Direct Oral Anticoagulant (DOAC); Type: EXPERIMENTAL; Interventions: Drug: Apixaban 5 MG | Arm Label: Left Atrial Appendage Closure (LAAC); Type: EXPERIMENTAL; Interventions: Device: left atrial appendage closure | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Apixaban 5 MG; Assigned to Arm(s): Direct Oral Anticoagulant (DOAC) | Intervention Type: DEVICE; Name: left atrial appendage closure; Assigned to Arm(s): Left Atrial Appendage Closure (LAAC)
B: Arm Label: Triple Pill (active treatment); Type: EXPERIMENTAL; Interventions: Drug: telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg; Assigned to Arm(s): Triple Pill (active treatment) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Edoxaban 60/30mg daily; Type: EXPERIMENTAL; Interventions: Drug: Edoxaban | Arm Label: Non-anticoagulant medical therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Non-anticoagulant medical therapy | Intervention Type: DRUG; Name: Edoxaban; Assigned to Arm(s): Edoxaban 60/30mg daily | Intervention Type: OTHER; Name: Non-anticoagulant medical therapy; Assigned to Arm(s): Non-anticoagulant medical therapy
D: Arm Label: DU-176b 15 mg group; Type: EXPERIMENTAL; Interventions: Drug: Du-176b | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Du-176b; Assigned to Arm(s): DU-176b 15 mg group | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study of DU-176b in Patients With NVAF Aged 80 Years or Older Who Are Ineligible for Available Oral Anticoagulation Therapy
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of edoxaban in patients with non-valvular NVAF aged 80 years or older who are ineligible for available oral anticoagulation therapy.


Options:
A: Arm Label: Dabigatran dose 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dabigatran dose 2 | Arm Label: Warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: warfarin | Arm Label: Dabigatran dose 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dabigatran dose 1 | Intervention Type: DRUG; Name: warfarin; Assigned to Arm(s): Warfarin | Intervention Type: DRUG; Name: Dabigatran dose 1; Assigned to Arm(s): Dabigatran dose 1 | Intervention Type: DRUG; Name: Dabigatran dose 2; Assigned to Arm(s): Dabigatran dose 2
B: Arm Label: Early initiation of DOAC; Type: EXPERIMENTAL; Interventions: Drug: Direct oral anticoagulant (DOAC) | Arm Label: Standard Initiation of DOAC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Direct oral anticoagulant (DOAC) | Intervention Type: DRUG; Name: Direct oral anticoagulant (DOAC); Assigned to Arm(s): Early initiation of DOAC, Standard Initiation of DOAC
C: Arm Label: DU-176b 15 mg group; Type: EXPERIMENTAL; Interventions: Drug: Du-176b | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Du-176b; Assigned to Arm(s): DU-176b 15 mg group | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo group
D: Arm Label: Rivaroxaban; Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban | Arm Label: Warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Warfarin | Intervention Type: DRUG; Name: Rivaroxaban; Assigned to Arm(s): Rivaroxaban | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Warfarin

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Use of a Foot Length Card to Improve Careseeking Practices of Vulnerable Newborns in Sarlahi District, Nepal
Brief Summary: This study will evaluate whether or not provision of a simple card ("footlength card") that allows identification of low birth weight and/or preterm babies through measurement of the length of a baby's foot, can improve basic newborn care behaviors in rural Nepal.


Options:
A: Arm Label: Durham Connects Eligible Group; Type: EXPERIMENTAL; Interventions: Other: Durham Connects | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Durham Connects; Assigned to Arm(s): Durham Connects Eligible Group
B: Arm Label: Philani Intervention Program; Type: EXPERIMENTAL; Interventions: Behavioral: Philani Intervention Program | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Philani Intervention Program; Assigned to Arm(s): Philani Intervention Program
C: Arm Label: Footlength Card; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Footlength Card | Arm Label: No Footlength Card; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Footlength Card; Assigned to Arm(s): Footlength Card
D: Arm Label: NBO, Newborn behavioral observation; Type: EXPERIMENTAL; Interventions: Behavioral: NBO, Newborn behavioral observation | Arm Label: Practice as usual; Type: EXPERIMENTAL; Interventions: Behavioral: Practice as usual | Intervention Type: BEHAVIORAL; Name: NBO, Newborn behavioral observation; Assigned to Arm(s): NBO, Newborn behavioral observation | Intervention Type: BEHAVIORAL; Name: Practice as usual; Assigned to Arm(s): Practice as usual

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tools And Practices To Decrease CVD And Complications In The Diabetic Population Of Mexico
Brief Summary: This project will look to improve standards of care for diabetic patients by evaluating a program that supports participants in making healthy lifestyle changes.

The program consists of 13 educational sessions that contain information about the prevention and care of diabetes and cardiovascular disease, physical activity, nutrition, community health and emotional well being.


Options:
A: Arm Label: Meta Salud Diabetes-Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Education intervention | Arm Label: Meta Salud Diabetes-Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education intervention; Assigned to Arm(s): Meta Salud Diabetes-Intervention
B: Arm Label: PrEP Prescription at Enrollment; Type: N/A; Interventions: N/A | Arm Label: No PrEP Prescription at Enrollment; Type: N/A; Interventions: N/A
C: Arm Label: Regimen A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Regimen A calcium and iron/folic acid | Arm Label: Regimen B; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Regimen B calcium and iron/folic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: Regimen A calcium and iron/folic acid; Assigned to Arm(s): Regimen A | Intervention Type: DIETARY_SUPPLEMENT; Name: Regimen B calcium and iron/folic acid; Assigned to Arm(s): Regimen B
D: Arm Label: ICC; Type: EXPERIMENTAL; Interventions: Other: Integrated collaborative care | Arm Label: E&R; Type: ACTIVE_COMPARATOR; Interventions: Other: Education and Resources | Intervention Type: OTHER; Name: Integrated collaborative care; Assigned to Arm(s): ICC | Intervention Type: OTHER; Name: Education and Resources; Assigned to Arm(s): E&R

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tools And Practices To Decrease CVD And Complications In The Diabetic Population Of Mexico
Brief Summary: This project will look to improve standards of care for diabetic patients by evaluating a program that supports participants in making healthy lifestyle changes.

The program consists of 13 educational sessions that contain information about the prevention and care of diabetes and cardiovascular disease, physical activity, nutrition, community health and emotional well being.


Options:
A: Arm Label: PrEP Prescription at Enrollment; Type: N/A; Interventions: N/A | Arm Label: No PrEP Prescription at Enrollment; Type: N/A; Interventions: N/A
B: Arm Label: Regimen A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Regimen A calcium and iron/folic acid | Arm Label: Regimen B; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Regimen B calcium and iron/folic acid | Intervention Type: DIETARY_SUPPLEMENT; Name: Regimen A calcium and iron/folic acid; Assigned to Arm(s): Regimen A | Intervention Type: DIETARY_SUPPLEMENT; Name: Regimen B calcium and iron/folic acid; Assigned to Arm(s): Regimen B
C: Arm Label: ICC; Type: EXPERIMENTAL; Interventions: Other: Integrated collaborative care | Arm Label: E&R; Type: ACTIVE_COMPARATOR; Interventions: Other: Education and Resources | Intervention Type: OTHER; Name: Integrated collaborative care; Assigned to Arm(s): ICC | Intervention Type: OTHER; Name: Education and Resources; Assigned to Arm(s): E&R
D: Arm Label: Meta Salud Diabetes-Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Education intervention | Arm Label: Meta Salud Diabetes-Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education intervention; Assigned to Arm(s): Meta Salud Diabetes-Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of a Focused Palliative Care Intervention for Recently Hospitalized High-Risk Patients With Heart Failure
Brief Summary: This small pilot study will be assessing the the impact of a standardized, social-worker led, longitudinal palliative care intervention on alignment of patient and physician understanding of prognosis and goals of care. Secondary objectives include assessing the impact of this intervention on documentation of advanced care planning and end of life preferences, symptom burden, quality of life and health care utilization.


Options:
A: Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: Assigned to palliative care team; Type: EXPERIMENTAL; Interventions: Behavioral: Assigned to palliative care team | Intervention Type: BEHAVIORAL; Name: Assigned to palliative care team; Assigned to Arm(s): Assigned to palliative care team | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual care
B: Arm Label: Routine data collection; Type: ACTIVE_COMPARATOR; Interventions: Other: Routine Data collection | Arm Label: Feedback of patient-reported outcomes; Type: EXPERIMENTAL; Interventions: Other: Routine Data collection, Other: Feedback of patient-reported outcomes | Intervention Type: OTHER; Name: Routine Data collection; Assigned to Arm(s): Feedback of patient-reported outcomes, Routine data collection | Intervention Type: OTHER; Name: Feedback of patient-reported outcomes; Assigned to Arm(s): Feedback of patient-reported outcomes
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Decision support skills building Intervention | Intervention Type: BEHAVIORAL; Name: Decision support skills building Intervention; Assigned to Arm(s): 1
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Arm Label: Verbal Information and Discussion; Type: EXPERIMENTAL; Interventions: Other: Verbal Information and Discussion | Intervention Type: OTHER; Name: Verbal Information and Discussion; Assigned to Arm(s): Verbal Information and Discussion | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control

Answer: D